A Review of EMA Recommendations on Decentralized Clinical Trial Elements
Read the EMA’s recommendations for decentralized elements in clinical trials. Learn how they support flexibility, patient access, and data collection.
Read the EMA’s recommendations for decentralized elements in clinical trials. Learn how they support flexibility, patient access, and data collection.
Get insights from the FDA’s draft guidance on decentralized trials, including technology apps, investigator oversight, and data precision strategies.
See the current phase of DCT adoption in this article by Signant’s experts; learn about the progress from early challenges to successful...